Articles related to Oncology, Medical

“At the end of the day, it’s vital to avoid overuse of opioids—when the harms would outweigh the benefits—but also to avoid underuse.” – Cary P. Gross, MD, Professor of Medicine at YSM

“When one oncologist leaves, the impact is not isolated, it’s felt across an entire community. Because in rural America, when care disappears, distance becomes the diagnosis.” — Harsha Vyas, MD, Cancer Center of Middle Georgia

“By comparing current standard-of-care treatments with a potential novel therapy in refractory mCRC, this review underscores existing gaps and highlights future research priorities while awaiting randomized data.” – Elisabetta Bengala, MD, Regina Elena National Cancer Institute, Rome, Italy

Disease recurrence in HR+/HER2– early BC (EBC) can occur over decades; however, the hazard of recurrence is highest during the first 2 years of adjuvant endocrine therapy, a period associated with endocrine resistance and early metastatic progression.

The primary end point was the area under the curve (AUC) of the daily worst bone pain score (assessed using the “worst pain” question from the Brief Pain Inventory, a 0 to 10 numerical rating scale [NRS]) for 5 consecutive days in the first chemotherapy cycle.

“A lot of our individuals are young, so we’ve seen this cancer being diagnosed during or after pregnancy, and often it gets labeled as hemorrhoids … but in hindsight, probably should have warranted attention earlier.” – Pashtoon Kasi, MD